- Home
- HEPA vs KTTA Comparison
HEPA vs KTTA Comparison
Compare HEPA & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- KTTA
- Stock Information
- Founded
- HEPA 2013
- KTTA 2020
- Country
- HEPA United States
- KTTA United States
- Employees
- HEPA N/A
- KTTA N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- HEPA Health Care
- KTTA Health Care
- Exchange
- HEPA Nasdaq
- KTTA Nasdaq
- Market Cap
- HEPA N/A
- KTTA 4.5M
- IPO Year
- HEPA N/A
- KTTA 2021
- Fundamental
- Price
- HEPA $0.75
- KTTA $3.99
- Analyst Decision
- HEPA Hold
- KTTA
- Analyst Count
- HEPA 1
- KTTA 0
- Target Price
- HEPA N/A
- KTTA N/A
- AVG Volume (30 Days)
- HEPA 20.2K
- KTTA 2.9M
- Earning Date
- HEPA 11-18-2024
- KTTA 11-11-2024
- Dividend Yield
- HEPA N/A
- KTTA N/A
- EPS Growth
- HEPA N/A
- KTTA N/A
- EPS
- HEPA N/A
- KTTA N/A
- Revenue
- HEPA N/A
- KTTA N/A
- Revenue This Year
- HEPA N/A
- KTTA N/A
- Revenue Next Year
- HEPA N/A
- KTTA N/A
- P/E Ratio
- HEPA N/A
- KTTA N/A
- Revenue Growth
- HEPA N/A
- KTTA N/A
- 52 Week Low
- HEPA $0.55
- KTTA $3.61
- 52 Week High
- HEPA $5.30
- KTTA $17.40
- Technical
- Relative Strength Index (RSI)
- HEPA 61.92
- KTTA 41.34
- Support Level
- HEPA $0.56
- KTTA $3.93
- Resistance Level
- HEPA $0.72
- KTTA $5.45
- Average True Range (ATR)
- HEPA 0.06
- KTTA 0.39
- MACD
- HEPA 0.01
- KTTA -0.13
- Stochastic Oscillator
- HEPA 57.91
- KTTA 2.80
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.